GDP
The United States economy defied gravity in the third quarter of 2025, posting a staggering 4.3% annualized growth rate that has sent shockwaves through global financial markets. Released on December 23, 2025—following a two-month delay caused by a late-autumn federal government shutdown—the Bureau of Economic Analysis (BEA)
Nvidia
As the final trading days of 2025 unfold, the financial world is witnessing a historic technical breakout from Nvidia (NASDAQ: NVDA) that has sent shockwaves through the broader semiconductor sector. After months of consolidation following its mid-year surge, Nvidia has decisively cleared the critical $194.17 resistance level—a mark
Stock Market
As 2025 draws to a close, the divergence between the "new economy" and the "old economy" has reached a historic fever pitch. While the S&P 500 has surged to record highs, fueled by an insatiable appetite for artificial intelligence and mega-cap technology, traditional cyclical
Amdocs
The final trading days of 2025 have brought an unexpected surge of volatility to the telecommunications software sector. On December 23, 2025, Amdocs (NASDAQ: DOX) witnessed a staggering spike in trading activity, characterized by an unusual explosion in call option volume. Traders snapped up over 3,600 call options—a
Citigroup
As 2025 draws to a close, the financial world is witnessing a transformation once thought impossible. Citigroup (NYSE: C) has emerged as the surprise champion of the banking sector, shedding its decade-long reputation as a "perpetual turnaround" story to become one of the top-performing stocks of the year.
Coinbase
As the final weeks of 2025 unfold, the digital asset market is grappling with a sharp correction that has seen Bitcoin retreat from its October highs of $126,000 to the $85,000 level. This 30% drawdown is more than just a seasonal dip; it represents the first major stress
Novo Nordisk
BAGSVAERD, Denmark — In a landmark decision that has sent shockwaves through the global pharmaceutical industry, Novo Nordisk (NYSE:NVO) has secured U.S. Food and Drug Administration (FDA) approval for the first-ever high-dose oral version of its blockbuster weight-loss treatment. The news, announced late yesterday on December 22, 2025, triggered
GDP
NEW YORK — In a dramatic conclusion to a year defined by political brinkmanship and economic uncertainty, the U.S. Bureau of Economic Analysis (BEA) released the long-delayed third-quarter Gross Domestic Product (GDP) report today, December 23, 2025. The data revealed a staggering 4.3% annualized growth rate, far outstripping the
Stock Market
As the sun sets on a volatile but ultimately record-breaking year, Wall Street has entered its final, holiday-shortened trading week of 2025. With the S&P 500 sitting at a historic peak of 6,904 as of December 23, investors are closely watching for the emergence of the "
Tariffs
As 2025 draws to a close, the American economic landscape stands fundamentally transformed by a series of aggressive trade policies that have redefined global supply chains and domestic manufacturing. The implementation of universal baseline tariffs and massive reciprocal levies—most notably the staggering 145% composite duty on Chinese imports—initially
Braze
As the financial world closes the books on 2025, a clear standout has emerged in the enterprise software sector. Braze (Nasdaq: BRZE), the customer engagement platform that once lived in the shadow of legacy marketing clouds, has officially hit an inflection point. In its most recent quarterly earnings report, the
Zebra Technologies
As the curtain closes on 2025, the financial narrative surrounding Zebra Technologies (NASDAQ: ZBRA) has undergone a dramatic transformation. Once a high-flying darling of the pandemic-era logistics boom, the Illinois-based leader in automatic identification and data capture (AIDC) has spent much of the last year in a grueling retreat. After